S&P 500   4,329.96 (-1.64%)
DOW   34,070.68 (-1.07%)
QQQ   358.79 (-1.58%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
S&P 500   4,329.96 (-1.64%)
DOW   34,070.68 (-1.07%)
QQQ   358.79 (-1.58%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
S&P 500   4,329.96 (-1.64%)
DOW   34,070.68 (-1.07%)
QQQ   358.79 (-1.58%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
S&P 500   4,329.96 (-1.64%)
DOW   34,070.68 (-1.07%)
QQQ   358.79 (-1.58%)
AAPL   174.03 (-0.83%)
MSFT   320.26 (-0.16%)
META   296.61 (-1.02%)
GOOGL   130.60 (-2.35%)
AMZN   129.52 (-4.26%)
TSLA   256.90 (-2.17%)
NVDA   411.32 (-2.62%)
NIO   8.49 (-3.74%)
BABA   84.13 (-1.88%)
AMD   96.13 (-4.20%)
T   15.30 (-1.61%)
F   12.20 (-1.29%)
MU   68.04 (-2.35%)
CGC   0.77 (-11.47%)
GE   113.08 (-1.54%)
DIS   82.79 (+0.28%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.75 (-3.47%)
NFLX   383.71 (-0.67%)
NASDAQ:UBX

Unity Biotechnology (UBX) Price Target & Analyst Ratings

$2.55
+0.08 (+3.24%)
(As of 03:51 PM ET)
Compare
Today's Range
$2.46
▼
$2.55
50-Day Range
$2.22
▼
$3.17
52-Week Range
$1.46
▼
$5.72
Volume
32,111 shs
Average Volume
264,890 shs
Market Capitalization
$37.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Unity Biotechnology Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$6.75
164.71% Upside
High Prediction$10.00
Average Prediction$6.75
Low Prediction$5.00
TypeCurrent
9/21/22 to 9/21/23		1 Month Ago
8/22/22 to 8/22/23		3 Months Ago
6/23/22 to 6/23/23		1 Year Ago
9/21/21 to 9/21/22
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$6.75$6.75$6.75$72.00
Predicted Upside164.71% Upside210.45% Upside240.26% Upside308.63% Upside
Get Unity Biotechnology Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter.


UBX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UBX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Unity Biotechnology Stock vs. The Competition

TypeUnity BiotechnologyMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.65
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside173.28% Upside1,475.62% Upside695.81% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Caufield
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy ➝ Buy$10.00+325.53%
6/26/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating		A. Argyrides
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Neutral
5/26/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$5.00 ➝ $6.00+120.59%
3/28/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$12.00 ➝ $6.00+207.69%
(Data available from 9/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












UBX Price Target - Frequently Asked Questions

What is Unity Biotechnology's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Unity Biotechnology stock is Moderate Buy based on the current 1 hold rating and 3 buy ratings for UBX. The average twelve-month price prediction for Unity Biotechnology is $6.75 with a high price target of $10.00 and a low price target of $5.00. Learn more on UBX's analyst rating history.

Do Wall Street analysts like Unity Biotechnology more than its competitors?

Analysts like Unity Biotechnology more than other Medical companies. The consensus rating score for Unity Biotechnology is 2.75 while the average consensus rating score for medical companies is 2.65. Learn more on how UBX compares to other companies.

Is Unity Biotechnology being downgraded by Wall Street analysts?

Over the previous 90 days, Unity Biotechnology's stock had 1 downgrade by analysts.

Does Unity Biotechnology's stock price have much upside?

According to analysts, Unity Biotechnology's stock has a predicted upside of 210.45% based on their 12-month price targets.

What analysts cover Unity Biotechnology?

Unity Biotechnology has been rated by HC Wainwright, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:UBX) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -